Showing results (151-160 of 195) with videos related to
Sort By:
Pageof 20
European Journal of Clinical Nutrition|May 14, 2021
Computed tomography (CT)-defined sarcopenia and myosteatosis are prevalent in patients with neuroendocrine neoplasms (NENs) treated with peptide receptor radionuclide therapy (PRRT)David L Chan, Stephen J Clarke, Alexander Engel, et al.World Journal of Nuclear Medicine|November 12, 2025
ARTnet Perspectives and Contributions to TheranosticsRoslyn J Francis, Dale L Bailey, Kathy Willowson, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 5, 2026
Efficacy of peptide receptor radionuclide therapy in patients with oligodiscordant gastroenteropancreatic neuroendocrine tumoursClaire Mok, Wallace Chow, Zahra Sabahi, et al.Journal of Nuclear Medicine Technology|December 9, 2025
Impact of Long-Axial-Field-of-View PET/CT Workflow on the Patient ExperienceJacky W T Chen, William I D Rae, Peter L Kench, et al.Heart (British Cardiac Society)|November 5, 2013
Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT studyEdmund Mt Lau, Dale L Bailey, Elizabeth A Bailey, et al.Scientific Reports|January 29, 2021
Overlooked potential of positrons in cancer therapyTakanori Hioki, Yaser H Gholami, Kelly J McKelvey, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2022
The Importance of Training, Accreditation, and Guidelines for the Practice of Theranostics: The Australian PerspectiveSze Ting Lee, Louise M Emmett, David A Pattison, et al.EJNMMI Research|May 25, 2017
Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysisKathy P Willowson, Aimee R Hayes, David L H Chan, et al.Asia Oceania Journal of Nuclear Medicine & Biology|February 2, 2026
Confirming the normal range for Mebrofenin liver function indicesKathy P Willowson, Geoff Schembri, Elizabeth A Bailey, et al.Practical Radiation Oncology|May 7, 2018
Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaAimee R Hayes, Dasantha Jayamanne, Edward Hsiao, et al.Pageof 20